As of May 22
| +0.01 / +1.32%|
The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 3.75, with a high estimate of 3.75 and a low estimate of 3.75. The median estimate represents a +387.01% increase from the last price of 0.77.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.